Sinoway Industrial Co., Ltd.

Apremilast 608141-41-9 Apremilast 608141-41-9

Apremilast 608141-41-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Apremilast

Name

Apremilast

Alias

Apremilast (CC-10004)

CAS NO.

608141-41-9

Molecular Formula

C22H24N2O7S

Molecular Weight

460.51

Quality Standard

99% min

Grade Standard

Medicine grade

Package Size

1kg packing

Use of Apremilast

Apremilast was approved by the USFDA in March 2014 for treatment of adults with active psoriatic arthritis. Apremilast is the first oral agent that is FDA-approved for the treatment of psoriatic arthritis and offers the convenience of oral dosing compared to treatment with biopharmaceuticals. In September 2014, the USFDA approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis.It is also being tested for its efficacy in treating other chronic inflammatory diseases such as ankylosing spondylitis, Behcet's disease, and rheumatoid arthritis.

COA of Apremilast

Items

Specifications

Results

Appearance

Off-white to white powder

Off-white powder

Related Substances

Any single unknown impurity≤0.1%

Total impurities:≤0.5%

0.09%

0.13%

Enantiomer

<0.5%

0.12%

Loss on drying

Not more than 0.5%

0.03%

Melting Point

154~158℃

155.6~156.7℃

Residue on ignition

Not more than 0.5%

0.01%

Residual solvents

Methanol <3000ppm

Ethanol <5000ppm

THF<720ppm

Acetonitrile<410ppm

Acetone <5000ppm

Dichloromethane <600ppm

560ppm

N.D.

N.D.

66ppm

800ppm

N.D.

Purity(HPLC)

≥99%

99.87%

Results

The product conforms to the above specifications.


  • Hydrocortisone 50-23-7
    Basic information:Product Name: HydrocortisoneMolecular Formula : C21H30O5Molecular Weight: 362.46CAS No.: 50-23-7Appearance: White crystalline powderSpecifications:EP6/USP37;EP8Usages :Treat for allergic... Hydrocortisone 50-23-7
  • Rivaroxaban 366789-02-8
    Basic information of Rivaroxaban :NameRivaroxabanAlias(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({... Rivaroxaban 366789-02-8
  • Galantamine 357-70-0
    Basic information of GalantamineNameGalantamineAliasGalantamine hydrobromCAS Number357-70-0Molecular FormulaC17H21NO3Molecular Weight287.35Quality StandardIn housePackage Size5kg/bag, 10kg/bag, accord... Galantamine 357-70-0
  • Sulfadimidine sodium 1981-58-4
    Basic information of Sulfadimidine sodium :NameSulfadimidine sodiumAlias4-AMINO-N-[4,6-DIMETHYL-2-PYRIMIDINYL]BENZENE-SULFONAMIDE SODIUM SALT;SULFADIMIDINE SODIUM;SULFAMETHAZINE SODIUM SALT;(n(sup1)-... Sulfadimidine sodium 1981-58-4

MORE_DETAIL Apremilast 608141-41-9

Basic information of Apremilast

Name

Apremilast

Alias

Apremilast (CC-10004)

CAS NO.

608141-41-9

Molecular Formula

C22H24N2O7S

Molecular Weight

460.51

Quality Standard

99% min

Grade Standard

Medicine grade

Package Size

1kg packing

Use of Apremilast

Apremilast was approved by the USFDA in March 2014 for treatment of adults with active psoriatic arthritis. Apremilast is the first oral agent that is FDA-approved for the treatment of psoriatic arthritis and offers the convenience of oral dosing compared to treatment with biopharmaceuticals. In September 2014, the USFDA approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis.It is also being tested for its efficacy in treating other chronic inflammatory diseases such as ankylosing spondylitis, Behcet's disease, and rheumatoid arthritis.

COA of Apremilast

Items

Specifications

Results

Appearance

Off-white to white powder

Off-white powder

Related Substances

Any single unknown impurity≤0.1%

Total impurities:≤0.5%

0.09%

0.13%

Enantiomer

<0.5%

0.12%

Loss on drying

Not more than 0.5%

0.03%

Melting Point

154~158℃

155.6~156.7℃

Residue on ignition

Not more than 0.5%

0.01%

Residual solvents

Methanol <3000ppm

Ethanol <5000ppm

THF<720ppm

Acetonitrile<410ppm

Acetone <5000ppm

Dichloromethane <600ppm

560ppm

N.D.

N.D.

66ppm

800ppm

N.D.

Purity(HPLC)

≥99%

99.87%

Results

The product conforms to the above specifications.

Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//